Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity
about
Multiple advantageous amino acid variants in the NAT2 gene in human populationsWorldwide distribution of NAT2 diversity: implications for NAT2 evolutionary historyDeciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes.Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibilityA case-only analysis of the interaction between N-acetyltransferase 2 haplotypes and tobacco smoke in breast cancer etiology.Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome.Inferring haplotypes at the NAT2 locus: the computational approach.Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discoveryPharmGKB summary: very important pharmacogene information for N-acetyltransferase 2N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.Smoking, the xenobiotic pathway, and clubfootAnalysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversityThe Non-Linear Child: Ontogeny, Isoniazid Concentration, and NAT2 Genotype Modulate Enzyme Reaction Kinetics and MetabolismPharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.N-acetyltransferase 2 (NAT2) gene polymorphisms in Parkinson's disease.Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancerInterethnic diversity of NAT2 polymorphisms in Brazilian admixed populations.Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction.Caffeine, selected metabolic gene variants, and risk for neural tube defects.NAT2 6A, a haplotype of the N-acetyltransferase 2 gene, is an important biomarker for risk of anti-tuberculosis drug-induced hepatotoxicity in Japanese patients with tuberculosis.N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patientsThe role of N-acetyltransferase 2 polymorphism in the etiopathogenesis of inflammatory bowel disease.Genetic variation in aryl N-acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3,4-diaminopyridine) phosphate.Crohn's disease in Japanese is associated with a SNP-haplotype of N-acetyltransferase 2 gene.alcohol, smoking, and caffeine in relation to fecundability, with effect modification by NAT2.Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes.Association between the N-acetylation genetic polymorphism and bronchial asthmaGlucuronidation and sulphation of paracetamol in HIV-positive patients and patients with AIDS.Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2.Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer.Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic studyEvaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapyStructure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2Development of a prediction system for anti-tuberculosis drug-induced liver injury in Japanese patients.Analysis association between mitochondrial genome instability and xenobiotic metabolizing genes in human breast cancer.Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer.N-Acetyltransferase polymorphism and human cancer risk.Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients.
P2860
Q21144240-4AAF0FEA-0D54-4D56-9A31-4468CE60EA33Q21283781-78436D76-6D19-4A74-92A3-BD7B2D3D7D87Q24540724-EE3CC453-9C31-4557-83BA-6C7E5FA21E5EQ24679438-EC141BF2-1F03-4B60-8D0D-3E748B020AC3Q24810267-B4D90D8C-7175-4014-BC61-79A858A89658Q24812002-0CAB7689-E326-4644-B07C-5ADE16DD364DQ24815593-B9490670-E8EA-4487-8BDF-877FEC1A4B3BQ26995125-CDFB856F-D99D-478B-87EB-5249E968DF52Q27011622-7E6654A4-034E-42DE-9C9B-3DBA46C28C5CQ28388128-A6F8F453-F1F6-46EB-922E-81B4DD8CC268Q28672873-92297C81-8C07-4A07-8477-69491DF906CAQ28744372-2F115C13-BC0D-4A73-AD04-4514E4C4BB53Q28822540-E7737BD2-B3F5-435A-9327-E9EC730E9933Q31144283-E118BA19-1549-43B4-8D37-E99CB4449CA2Q33237936-5212EA1F-48B6-4DA2-B01C-B88BA4246139Q33608783-37C97510-9A96-4FAB-B5DD-4B8C2F5B7080Q33710997-E42AB0C2-8497-4542-8790-ED8769CA4E84Q33770163-DE27ECDB-44CF-4E01-91A1-769BD16E3D1AQ33985340-7C0107B3-2DB5-4BB8-A8F2-E831B239AECCQ34051331-41FDEF8E-173A-4FAC-8581-B92DC74A7ED1Q34606196-60986ADA-6DA1-40AC-882F-D17D1D6295BFQ34944536-5CA0D182-07B0-48DF-895B-A8D76AE19F12Q35038737-3A9FB926-32F2-4241-B17F-FB9FA4B929D8Q35049590-F752821B-7D80-4905-B1AE-3EEDFD64B66AQ35435673-92D0B8BB-BB39-4A8E-9ABE-BACB89B02F5EQ35467782-CB8A4524-D28D-4883-9713-9E7FE4D27B0CQ35774965-4BD85272-FB38-4F7E-8C43-7380A5298055Q35804167-CC1AC7A5-7088-4875-A5F8-5BF1E29CA63EQ36053659-7272331E-2F67-4519-80BD-959238435D0CQ36158505-CCC7DD6B-9096-4510-83BB-1498121F873DQ36408201-D2026371-9D50-4E45-A5DA-27ED45B116C6Q36447072-7303CE1D-A9D9-4EE9-AF40-B505E503D383Q36747900-22EDA590-F21E-433B-83A7-AD71F9681343Q36809405-3A830647-1A1A-4AFA-897B-CF3022668EDAQ36828813-D537D509-3D1F-44CC-8C7A-57B431BB06A7Q37030180-86EB0BD3-B6A1-4C93-A8BC-BA90F0D6B33BQ37126201-ADB74F0F-A27F-471B-BCBE-738E836F43EFQ37221665-36C02F8B-2141-4D96-A445-311CEF818EB7Q37296621-26734E5A-7749-4597-B942-8DBB3A68C98CQ37411216-411876B0-0F07-462A-8DCA-2BFC65C6932D
P2860
Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Arylamine N-acetyltransferase ...... ation with phenotypic activity
@ast
Arylamine N-acetyltransferase ...... ation with phenotypic activity
@en
type
label
Arylamine N-acetyltransferase ...... ation with phenotypic activity
@ast
Arylamine N-acetyltransferase ...... ation with phenotypic activity
@en
prefLabel
Arylamine N-acetyltransferase ...... ation with phenotypic activity
@ast
Arylamine N-acetyltransferase ...... ation with phenotypic activity
@en
P2093
P2860
P1476
Arylamine N-acetyltransferase ...... ation with phenotypic activity
@en
P2093
Brockmöller J
Cascorbi I
Drakoulis N
Sperling K
P2860
P304
P407
P577
1995-09-01T00:00:00Z